Impact of Survivorship Care Planning of Oncology Care at the End of Treatment for Breast Cancer: A Randomized Controlled Trial

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 48

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ARCHB-9-1_014

تاریخ نمایه سازی: 14 آذر 1402

Abstract:

Background: In ۲۰۰۶, the Institute of Medicine (IOM) issued a report recommending that all cancer survivors receive a customized survivorship care plan (SCP) to increase survivors’ understanding of diagnoses, long-term treatment effects, and ideas for improving overall health. Therefore, the purpose of this study was to compare a tailored SCP program (POST) to treatment as usual (TAU) on patient ratings of quality and content of discussion with providers at the end of their breast cancer treatment. Methods: Two hundred participants were randomized to receive either the POST treatment (n=۱۰۰) or TAU (n=۱۰۰) at their last treatment visit. Women were presented with a checklist of ۲۹ survivorship topics and indicated whether their healthcare provider discussed it at their last visit. They were also asked to rate overall quality of discussion (QOD) with their providers and across several QOD subscales. Results: Analyses indicated that on average, POST women endorsed ۲۰ out of the ۲۹ topics compared to ۱۴ topics endorsed by TAU. Additionally, POST women reported a better QOD overall and across all subscales. Conclusion: POST women remembered discussing more survivorship topics and reported better discussions with their providers. As a practical implication, cancer survivors should receive an individualized SCP to ensure that patients feel well informed of their road to survivorship.

Authors

Shannon Williamson-Butler

Impact of Survivorship Care Planning of Oncology Care at the End of Treatment for Breast Cancer: A Randomized Controlled Trial

Samantha Creamer

Department of Psychiatry, University of Massachusetts Medical School, Worcester, USA

Mulie M Flahive

Department of Population and Quantitative Health Science, University of Massachusetts, Worcester, USA

Beth A Keating

Department of Hematology/Oncology, University of Massachusetts Medical School, Worcester, USA